InVitria Expands Manufacturing Capability to Meet Demand for Lysobac

| Print |
Wednesday, 11 November 2009 11:30 (UTC + 1)

invitria_flag_1

InVitria Reports Expanded Manufacturing Capability to Meet Commercial Demand for Lysobac, an Animal Free Reagent for Bacterial Fermentation

 

InVitria’s Lysobac is a high potency, animal free and consistent alternative to chicken lysozyme, which is used in bacterial cell lysis. Tests prove Lysobac is greater than 4 times more active than chicken lysozyme and increases protein yield from bacterial fermentation.

 

Fort Collins, CO, November 11, 2009 / b3c newswire / – Manufactured in an animal free production system, InVitria’s Lysobac is a cost-effective, more consistent and performance enhancing alternative to chicken lysozyme, also called hen egg white lysozyme (HEWL).

 

Now, InVitria will meet the demand of large commercial users who require metric ton quantities of bacterial cell lysis reagents. "With the increase in production capacity at our ISO 9001 facility, we now have the ability to supply large volumes of Lysobac to commercial customers all over the world," said Greg Unruh, Vice President of Production.

 

"InVitria customers have achieved significant performance and safety benefits from using Lysobac as a cell lysis reagent," said Scott Deeter, President and CEO. "Further, Lysobac allows manufacturers to switch to an animal free production system and avoid the risk of contaminants from animal derived components," said Deeter.

 

Lysobac offers substantial advantages over chicken lysozyme and mechanical lysis, including:

 

• Animal free
• Greater than 4x more active than chicken lysozyme (units/mg protein)
• Delivers more recombinant protein yield
• Consistent from lot-to-lot
• Improves bioprocessing efficiency
• Reduces overall production costs

 

Through December 1, 2009, InVitria is offering a FREE Papa John’s Pizza gift card for all Lysobac orders placed through InVitria’s WebStore. Visit www.lysobac.com to place your order.

 

 

About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media and bacterial cell lysis supplements and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

 

For more information about InVitria’s products, please contact InVitria’s Product Support team at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or call 1-800-916-8311.